Biblio

Found 49 results
Filters: Author is Kaaks, Rudolf  [Clear All Filters]
2012
Grote VA, Rohrmann S, Dossus L, Nieters A, Halkjaer J, Tjønneland A, Overvad K, Stegger J, Chabbert-Buffet N, Boutron-Ruault M-C et al..  2012.  The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort.. Int J Cancer. 130(10):2428-37.
Grote VA, Nieters A, Kaaks R, Tjønneland A, Roswall N, Overvad K, Nielsen M SR, Clavel-Chapelon F, Boutron-Ruault M C, Racine A et al..  2012.  The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.. Cancer Epidemiol Biomarkers Prev. 21(4):619-28.
Romaguera D, Vergnaud A-C, Peeters PH, van Gils CH, Chan DSM, Ferrari P, Romieu I, Jenab M, Slimani N, Clavel-Chapelon F et al..  2012.  Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr. 96(1):150-63.
Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B, Skeie G, Dahm CC, Overvad K, Olsen A, Tjønneland A et al..  2012.  Dietary fibre intake and risks of cancers of the colon and rectum in the European prospective investigation into cancer and nutrition (EPIC).. PLoS One. 7(6):e39361.
Chuang S-C, Norat T, Murphy N, Olsen A, Tjønneland A, Overvad K, Boutron-Ruault M C, Perquier F, Dartois L, Kaaks R et al..  2012.  Fiber intake and total and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition cohort.. Am J Clin Nutr. 96(1):164-74.
Duell EJ, Sala N, Travier N, Muñoz X, Boutron-Ruault M C, Clavel-Chapelon F, Barricarte A, Arriola L, Navarro C, Sánchez-Cantalejo E et al..  2012.  Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.. Carcinogenesis. 33(2):361-7.
Agudo A, Bonet C, Travier N, González CA, Vineis P, Bueno-de-Mesquita BH, Trichopoulos D, Boffetta P, Clavel-Chapelon F, Boutron-Ruault M-C et al..  2012.  Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study.. J Clin Oncol. 30(36):4550-7.
Brennan K, Garcia-Closas M, Orr N, Fletcher O, Jones M, Ashworth A, Swerdlow A, Thorne H, Riboli E, Vineis P et al..  2012.  Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk.. Cancer Res. 72(9):2304-13.
Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita BH, Jansen E, van Duijnhoven FJB, Rinaldi S, Fedirko V, Romieu I, Riboli E et al..  2012.  Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort.. Cancer Res. 72(20):5328-37.
Travier N, Agudo A, May AM, Gonzalez C, Luan J'an, Wareham NJ, Bueno-de-Mesquita BH, van den Berg SW, Slimani N, Rinaldi S et al..  2012.  Longitudinal changes in weight in relation to smoking cessation in participants of the EPIC-PANACEA study.. Prev Med. 54(3-4):183-92.
Sacerdote C, Ricceri F, Rolandsson O, Baldi I, Chirlaque M-D, Feskens E, Bendinelli B, Ardanaz E, Arriola L, Balkau B et al..  2012.  Lower educational level is a predictor of incident type 2 diabetes in European countries: The EPIC-InterAct study.. Int J Epidemiol. 41(4):1162-1173.
Michaud DS, Izard J, Wilhelm-Benartzi CS, You D-H, Grote VA, Tjønneland A, Dahm CC, Overvad K, Jenab M, Fedirko V et al..  2012.  Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.. Gut.
Leenders M, Chuang S-C, Dahm CC, Overvad K, Ueland P M, Midttun O, Vollset S E, Tjønneland A, Halkjaer J, Jenab M et al..  2012.  Plasma cotinine levels and pancreatic cancer in the EPIC cohort study.. Int J Cancer. 131(4):997-1002.
Travis RC, Allen NE, Appleby PN, Price A, Kaaks R, Chang-Claude J, Boeing H, Aleksandrova K, Tjønneland A, Johnsen N F et al..  2012.  Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC.. Cancer Causes Control. 23(7):1163-71.
Sala N, Muñoz X, Travier N, Agudo A, Duell EJ, Moreno V, Overvad K, Tjonneland A, Boutron-Ruault M C, Clavel-Chapelon F et al..  2012.  Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study.. Int J Cancer. 130(10):2417-27.
Hoggart C, Brennan P, Tjonneland A, Vogel U, Overvad K, Østergaard J N, Kaaks R, Canzian F, Boeing H, Steffen A et al..  2012.  A risk model for lung cancer incidence.. Cancer Prev Res (Phila). 5(6):834-46.